Naobios and FluGen alliance continues: Production of intranasal flu vaccine clinical batches to get underway

Naobios and FluGen alliance continues: Production of intranasal flu vaccine clinical batches to get underway

Source: 
Biopharma Reporter
snippet: 

Naobios says its development work and GMP manufacturing of vaccine clinical batches will enable FluGen to prepare its 2022 clinical trials in the US.